EP0502105A4 - Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens - Google Patents
Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogensInfo
- Publication number
- EP0502105A4 EP0502105A4 EP19910900526 EP91900526A EP0502105A4 EP 0502105 A4 EP0502105 A4 EP 0502105A4 EP 19910900526 EP19910900526 EP 19910900526 EP 91900526 A EP91900526 A EP 91900526A EP 0502105 A4 EP0502105 A4 EP 0502105A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- immunogens
- particles used
- antiviral agents
- retroviral particles
- replicating recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
- 230000001177 retroviral effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43920589A | 1989-11-20 | 1989-11-20 | |
US439205 | 1989-11-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0502105A1 EP0502105A1 (en) | 1992-09-09 |
EP0502105A4 true EP0502105A4 (en) | 1993-02-24 |
Family
ID=23743729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19910900526 Withdrawn EP0502105A4 (en) | 1989-11-20 | 1990-11-20 | Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0502105A4 (en) |
JP (1) | JPH05503629A (en) |
KR (1) | KR920703639A (en) |
AU (1) | AU636944B2 (en) |
CA (1) | CA2068713A1 (en) |
ES (1) | ES2052478T1 (en) |
FI (1) | FI922277A (en) |
GR (1) | GR930300005T1 (en) |
HU (1) | HUT60506A (en) |
NO (1) | NO921969L (en) |
OA (1) | OA09698A (en) |
TW (1) | TW216446B (en) |
WO (1) | WO1991007425A1 (en) |
ZA (1) | ZA909302B (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0431128B1 (en) * | 1989-06-01 | 2003-03-26 | Applied Biotechnology, Inc. | Vector coding for self-assembled, defective, non-self-propagating viral particles |
US5861282A (en) * | 1989-10-16 | 1999-01-19 | Whitehead Institute For Biomedical Research | Non-infectious HIV particles and uses therefor |
WO1991019803A1 (en) * | 1990-06-19 | 1991-12-26 | Applied Biotechnology, Incorporated | Self assembled, defective, nonself-propagating viral particles |
DE4124817A1 (en) * | 1991-07-26 | 1993-01-28 | Basf Ag | AQUEOUS POLYMER DISPERSIONS |
DK0611397T3 (en) * | 1991-11-08 | 2002-10-07 | Upjohn Co | Vaccine against cat leukemia virus |
CA2118026A1 (en) * | 1992-04-14 | 1993-10-28 | Guy T. Layton | Induction of ctl responses |
DK1473369T3 (en) | 1993-01-26 | 2009-03-09 | Univ Pennsylvania | Preparations and methods for administering genetic material |
DE69434469T2 (en) | 1993-01-26 | 2006-06-14 | Univ Pennsylvania | COMPOSITIONS AND METHOD FOR THE ADMINISTRATION OF GENETIC MATERIAL |
US7001759B1 (en) | 1993-01-26 | 2006-02-21 | The Trustees Of The University Of Pennsylvania | Compositions and methods for delivery of genetic material |
GB9304239D0 (en) * | 1993-03-01 | 1993-04-21 | British Bio Technology | Viral particles |
US5955342A (en) * | 1994-08-15 | 1999-09-21 | Connaught Laboratories Limited | Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region |
US6291157B1 (en) | 1998-02-23 | 2001-09-18 | Connaught Laboratories Limited | Antigenically-marked non-infectious retrovirus-like particles |
US5858838A (en) | 1998-02-23 | 1999-01-12 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate |
US6080408A (en) | 1994-08-22 | 2000-06-27 | Connaught Laboratories Limited | Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles |
CN1185811A (en) * | 1995-03-31 | 1998-06-24 | H·沃尔夫 | Antigen presentation system on retrovirus-like particles |
US6013506A (en) * | 1995-06-05 | 2000-01-11 | Wardley; Richard C. | Feline leukemia virus vaccines |
US6121021A (en) * | 1997-12-16 | 2000-09-19 | Connaught Laboratories Limited | Constitutive expression of non-infectious HIV-like particles |
EP1141314A2 (en) | 1998-12-31 | 2001-10-10 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
AU2596600A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Modified hiv env polypeptides |
WO2002072754A2 (en) * | 2001-03-08 | 2002-09-19 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mva expressing modified hiv envelope, gag, and pol genes |
US8623379B2 (en) | 2000-03-02 | 2014-01-07 | Emory University | Compositions and methods for generating an immune response |
EP1418940A4 (en) | 2000-03-02 | 2006-09-20 | Univ Emory | Dna expression vectors and methods of use |
AU2002320314A1 (en) | 2001-07-05 | 2003-01-21 | Chiron, Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
US20030170614A1 (en) | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
DK2694101T3 (en) | 2011-04-06 | 2017-01-09 | Biovaxim Ltd | Pharmaceutical compositions for the prevention and / or treatment of HIV disease in humans |
EP4218805A1 (en) | 2015-07-21 | 2023-08-02 | ModernaTX, Inc. | Infectious disease vaccines |
WO2018170270A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Varicella zoster virus (vzv) vaccine |
WO2018170256A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Herpes simplex virus vaccine |
EP3938379A4 (en) * | 2019-03-15 | 2023-02-22 | ModernaTX, Inc. | Hiv rna vaccines |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0241239A2 (en) * | 1986-04-07 | 1987-10-14 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | A cell line producing aids viral antigens without producing infectious virus particles |
EP0381146A1 (en) * | 1989-02-02 | 1990-08-08 | Banyu Pharmaceutical Co., Ltd. | Antigenic noninfectious HIV-producing cloned T cell |
EP0386882A1 (en) * | 1989-02-06 | 1990-09-12 | Dana Farber Cancer Institute | Packaging defective HIV provirus, cell lines, and uses thereof |
WO1991005860A1 (en) * | 1989-10-16 | 1991-05-02 | Whitehead Institute For Biomedical Research | Non-infectious hiv-1 particles and uses therefor |
WO1991005864A1 (en) * | 1989-10-13 | 1991-05-02 | Connaught Laboratories Limited | Production of genetically-engineered vaccines for aids and other retroviral diseases |
-
1990
- 1990-11-20 HU HU9201659A patent/HUT60506A/en unknown
- 1990-11-20 WO PCT/US1990/006798 patent/WO1991007425A1/en not_active Application Discontinuation
- 1990-11-20 KR KR1019920701189A patent/KR920703639A/en not_active Application Discontinuation
- 1990-11-20 ZA ZA909302A patent/ZA909302B/en unknown
- 1990-11-20 AU AU69055/91A patent/AU636944B2/en not_active Ceased
- 1990-11-20 ES ES91900526T patent/ES2052478T1/en active Pending
- 1990-11-20 EP EP19910900526 patent/EP0502105A4/en not_active Withdrawn
- 1990-11-20 CA CA002068713A patent/CA2068713A1/en not_active Abandoned
- 1990-11-20 JP JP3501082A patent/JPH05503629A/en active Pending
-
1991
- 1991-01-12 TW TW080100246A patent/TW216446B/zh active
-
1992
- 1992-05-19 OA OA60209A patent/OA09698A/en unknown
- 1992-05-19 NO NO92921969A patent/NO921969L/en unknown
- 1992-05-19 FI FI922277A patent/FI922277A/en not_active Application Discontinuation
-
1993
- 1993-04-28 GR GR930300005T patent/GR930300005T1/el unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0241239A2 (en) * | 1986-04-07 | 1987-10-14 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | A cell line producing aids viral antigens without producing infectious virus particles |
EP0381146A1 (en) * | 1989-02-02 | 1990-08-08 | Banyu Pharmaceutical Co., Ltd. | Antigenic noninfectious HIV-producing cloned T cell |
EP0386882A1 (en) * | 1989-02-06 | 1990-09-12 | Dana Farber Cancer Institute | Packaging defective HIV provirus, cell lines, and uses thereof |
WO1991005864A1 (en) * | 1989-10-13 | 1991-05-02 | Connaught Laboratories Limited | Production of genetically-engineered vaccines for aids and other retroviral diseases |
WO1991005860A1 (en) * | 1989-10-16 | 1991-05-02 | Whitehead Institute For Biomedical Research | Non-infectious hiv-1 particles and uses therefor |
Non-Patent Citations (6)
Title |
---|
AIDS RES. HUM. RETROVIRUSES vol. 6, no. 1, 1990, page 63 V. KARAKOSTAS 'Assembly of retrovitus particles lacking env protein in cells infected with recombinant vaccinia virus expressing the HIV1' * |
J. VIROL. vol. 63, no. 6, 1989, pages 2550 - 2556 C. PENG ET AL. 'Role of hiv type 1 specific protease' * |
J. VIROL. vol. 64, no. 6, 1990, pages 2653 - 2659 O. HAFFAR ET AL. 'HIV-like nonreplicating gag-env particles assemble in a recombinant vaccinia virus expression system' * |
PROC. NATL. ACAD. SCI. USA vol. 86, no. 22, 1989, pages 8964 - 8967 V. KARAKOSTAS 'HIV-like particles produced by a vaccinia virus expression vector' * |
See also references of WO9107425A1 * |
VIROLOGY vol. 160, no. 2, 1987, pages 323 - 329 H. GENDELMAN ET AL. 'Molecular characterisation of a polymerase mutant human HIV' * |
Also Published As
Publication number | Publication date |
---|---|
JPH05503629A (en) | 1993-06-17 |
OA09698A (en) | 1993-08-30 |
GR930300005T1 (en) | 1993-04-28 |
CA2068713A1 (en) | 1991-05-21 |
KR920703639A (en) | 1992-12-18 |
ZA909302B (en) | 1991-09-25 |
HUT60506A (en) | 1992-09-28 |
EP0502105A1 (en) | 1992-09-09 |
NO921969D0 (en) | 1992-05-19 |
TW216446B (en) | 1993-11-21 |
FI922277A0 (en) | 1992-05-19 |
ES2052478T1 (en) | 1994-07-16 |
NO921969L (en) | 1992-06-26 |
AU6905591A (en) | 1991-06-13 |
HU9201659D0 (en) | 1992-08-28 |
WO1991007425A1 (en) | 1991-05-30 |
AU636944B2 (en) | 1993-05-13 |
FI922277A (en) | 1992-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0502105A4 (en) | Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens | |
ZA875671B (en) | Titanocenes and their use | |
PH21379A (en) | N-phenylsulfonyl-n'-pyrimidinyl and triazinyl-ureas | |
PH25866A (en) | Sulfonylurea compounds and their herbicides | |
ZA875672B (en) | Titanocenes and their use | |
ZA846525B (en) | (substituted)phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof | |
EP0137242A3 (en) | (substituted) phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof | |
PH27609A (en) | Antiviral agents | |
ZA873073B (en) | Thiazolotriazole herbicides | |
GB8610531D0 (en) | Herbicides | |
IL82798A0 (en) | Substituted 3-amino-2-benzoyl-cyclohex-2-enones and their use as herbicides | |
EP0406416A4 (en) | Anti-hiv agent | |
EP0450065A4 (en) | Antiviral agent | |
GB2184944B (en) | Antiviral agents | |
GB8911158D0 (en) | Antiviral pyridazinamines | |
EP0243192A3 (en) | Antiviral 8-phenylxanthines | |
GB2230751B (en) | Aerospace structures | |
PH27414A (en) | 1,2,4-oxadiazolyl-phenoxy-alkylisoxazoles and their use as antiviral agents | |
EP0440710A4 (en) | New antiviral agents | |
GB2190824B (en) | Pendant | |
GB8612062D0 (en) | Herbicides | |
GB8610532D0 (en) | Herbicides | |
GB8612616D0 (en) | Alpha-alumina particles | |
GB8617948D0 (en) | Phenoxybenzisoxazole herbicides | |
KR890003653Y1 (en) | Protractor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19920515 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TRAVIS, BRUCE, M. Inventor name: SENEAR, ALLEN, W. Inventor name: HU, SHIU-LOK Inventor name: HAFFAR, OMAR, K. |
|
ITCL | It: translation for ep claims filed |
Representative=s name: JACOBACCI CASETTA & PERANI S.P.A. |
|
EL | Fr: translation of claims filed | ||
TCNL | Nl: translation of patent claims filed | ||
TCAT | At: translation of patent claims filed | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 19930105 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: BA2A Ref document number: 2052478 Country of ref document: ES Kind code of ref document: T1 |
|
17Q | First examination report despatched |
Effective date: 19970213 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19990612 |